bpc 157 regenerative study BPC-157: A New Frontier in Medicine: 9798314939314: Schaeffer, KM: Books bpc 157 human studies randomized

This suggests that FOXO4-DRI may selectively target and eliminate senescent cells, potentially alleviating some dysfunctions associated with aged Leydig cells, such as reduced testosterone synthesis

Djinovic-Carugo and Carugo, 2015

But the treatment is so new that researchers have many questions to resolve about the best formulas and techniques

Concurrently, BPC-157 appears to temper excessive inflammation by reducing levels of pro-inflammatory cytokines, which can otherwise prolong pain and swelling

Factors that limit results include inadequate protein intake, metabolic adaptation, medication non-compliance, and unrealistic timelines